NBE-Therapeutics raised €19M in a Series B round in Nov 2016. The company is based in Basel, Switzerland. Investors in the round: Boehringer Ingelheim Venture Fund, PPF Group. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €19M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
